1. To review the rationale for the trial in the context of therapies for advanced melanoma
  2. To review the study design and results
  3. To present this study to oncology peers in preparation for the ASCO meeting


Session date: 
05/21/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel Olson, MD